| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,239 |
24,642 |
$1.68M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,846 |
7,593 |
$633K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,380 |
2,377 |
$217K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,764 |
2,720 |
$108K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,622 |
2,594 |
$70K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
791 |
785 |
$69K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
642 |
642 |
$60K |
| 99442 |
|
981 |
971 |
$51K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
184 |
184 |
$25K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
958 |
958 |
$25K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,489 |
1,487 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,080 |
1,073 |
$16K |
| 99454 |
|
1,010 |
1,008 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
77 |
77 |
$7K |
| 87807 |
|
514 |
505 |
$6K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
918 |
918 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
323 |
311 |
$5K |
| 99457 |
|
683 |
652 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
76 |
76 |
$3K |
| 99443 |
|
27 |
27 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
84 |
74 |
$2K |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
84 |
84 |
$1K |
| 99305 |
|
12 |
12 |
$862.46 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
30 |
26 |
$808.77 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
150 |
131 |
$660.04 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
421 |
417 |
$407.79 |
| 99458 |
|
43 |
32 |
$229.99 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
55 |
55 |
$229.05 |
| 90474 |
|
12 |
12 |
$209.64 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
94 |
94 |
$174.07 |
| 99453 |
|
77 |
77 |
$151.91 |
| 90686 |
|
48 |
48 |
$87.67 |
| 84703 |
|
13 |
13 |
$86.97 |
| 90670 |
|
191 |
191 |
$0.00 |
| 90710 |
|
27 |
27 |
$0.00 |
| 96160 |
|
86 |
86 |
$0.00 |
| 90697 |
|
27 |
27 |
$0.00 |
| 90680 |
|
25 |
25 |
$0.00 |